Radioembolization lung shunt estimation based on a 90Y pretreatment procedure: A phantom study
暂无分享,去创建一个
Max A. Viergever | Remco Bastiaannet | Sandra van der Velden | Marnix G. E. H. Lam | Britt Kunnen | M. Viergever | B. Kunnen | H. de Jong | M. Lam | R. Bastiaannet | Hugo W. A. M. de Jong | S. van der Velden
[1] T. Hellevik,et al. Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation , 2014, Front. Oncol..
[2] D. Ganger,et al. Same-day 90Y radioembolization: implementing a new treatment paradigm , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[3] H. de Jong,et al. Quantitative Evaluation of Scintillation Camera Imaging Characteristics of Isotopes Used in Liver Radioembolization , 2011, PloS one.
[4] Johan Nuyts,et al. Bias Reduction for Low-Statistics PET: Maximum Likelihood Reconstruction With a Modified Poisson Distribution , 2015, IEEE Transactions on Medical Imaging.
[5] Marnix G E H Lam,et al. Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres , 2015, The Journal of Nuclear Medicine.
[6] P. Xia,et al. Lung dose calculation with SPECT/CT for ⁹⁰Yittrium radioembolization of liver cancer. , 2013, International journal of radiation oncology, biology, physics.
[7] Alexander S. Pasciak,et al. Radioembolization and the Dynamic Role of 90Y PET/CT , 2014, Front. Oncol..
[8] M. A. van den Bosch,et al. 90Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments , 2015, The Journal of Nuclear Medicine.
[9] M. Viergever,et al. 99mTc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with 166Ho-microspheres , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[10] Jeroen Mertens,et al. 99mTc-labelled macroaggregated albumin (MAA) scintigraphy for planning treatment with 90Y microspheres , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[11] A. Rahmim,et al. Low-dose 90Y PET/CT imaging optimized for lesion detectability and quantitative accuracy: a phantom study to assess the feasibility of pretherapy imaging to plan the therapeutic dose , 2017, Nuclear medicine communications.
[12] M. A. van den Bosch,et al. Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study. , 2012, The Lancet. Oncology.
[13] Max A. Viergever,et al. Quantitative Monte Carlo–Based 90Y SPECT Reconstruction , 2013, The Journal of Nuclear Medicine.
[14] D. Townsend,et al. Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres , 2013, EJNMMI Research.
[15] Alessandro Radaelli,et al. Clinical impact of cone beam computed tomography on iterative treatment planning during ultrasound-guided percutaneous ablation of liver malignancies , 2017, Medical Oncology.
[16] Maurizio Conti,et al. (90)Y -PET imaging: Exploring limitations and accuracy under conditions of low counts and high random fraction. , 2015, Medical physics.
[17] L A DeWerd,et al. A new internal pair production branching ratio of 90Y: the development of a non-destructive assay for 90Y and 90Sr. , 2007, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[18] G. Lucignani,et al. Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis , 2017, Medical Oncology.
[19] Abass Alavi,et al. Insights into the Dose–Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases , 2016, The Journal of Nuclear Medicine.
[20] C. Bodet-Milin,et al. Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT , 2013, EJNMMI Research.
[21] Michael Tapner,et al. A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[22] S. Gulec,et al. Dosimetric techniques in 90Y-microsphere therapy of liver cancer: The MIRD equations for dose calculations. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] Marnix G. E. H. Lam,et al. Quantitative Comparison of PET and Bremsstrahlung SPECT for Imaging the In Vivo Yttrium-90 Microsphere Distribution after Liver Radioembolization , 2013, PloS one.
[24] J C Hung,et al. Evaluation of macroaggregated albumin particle sizes for use in pulmonary shunt patient studies. , 2000, Journal of the American Pharmaceutical Association.
[25] S. Jalkanen,et al. Nuclear imaging of inflammation: homing-associated molecules as targets , 2013, EJNMMI Research.
[26] Kathy Willowson,et al. Quantitative and Qualitative Assessment of Yttrium-90 PET/CT Imaging , 2014, PloS one.
[27] D. Bailey,et al. Quantitative (90)Y image reconstruction in PET. , 2012, Medical physics.
[28] D. Sze,et al. Radioembolization Dosimetry: The Road Ahead , 2015, CardioVascular and Interventional Radiology.
[29] Ashfaq Mahmood,et al. Adsorption of metallic radionuclides on plastic phantom walls. , 2008, Medical physics.
[30] Jeffrey A. Fessler,et al. Improved quantitative 90Y bremsstrahlung SPECT/CT reconstruction with Monte Carlo scatter modeling , 2017, Medical physics.
[31] Max A. Viergever,et al. elastix: A Toolbox for Intensity-Based Medical Image Registration , 2010, IEEE Transactions on Medical Imaging.
[32] Marnix G. E. H. Lam,et al. Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study , 2017, European Radiology.